The Impact of Coffee on Atrial Fibrillation: New Insights

Understanding the Caffeine Conundrum

Many are aware that excessive caffeine consumption can elevate heart rates, leading to common medical advice for individuals with heart conditions or high blood pressure to avoid coffee. However, recent findings from cardiologists at UCSF in San Francisco suggest that this may not hold true for all heart conditions, particularly atrial fibrillation or flutter. For certain patients, coffee may not only be harmless but could even offer benefits.

Research Findings on Coffee and Atrial Fibrillation

In a study published on November 7, 2025, in JAMA, UCSF cardiologists presented data from the DECAF clinical trial, which explored the effects of coffee on patients with atrial fibrillation and flutter. This open-label randomized controlled trial involved 200 patients who underwent cardioversion to address their atrial issues. Remarkably, the study found that consuming a daily cup of coffee reduced the risk of experiencing an episode by 40% over six months.

Key Observations and Limitations

It is crucial to note that the main takeaway from the study is that regular coffee drinkers did not face an increased risk of triggering atrial fibrillation compared to non-drinkers. Specifically, coffee drinkers had a 47% likelihood of experiencing a recurrence, while abstainers faced a 64% chance. Despite the study’s randomized and controlled design, participants were aware of their coffee consumption, which may have introduced biases. Additionally, some individuals might have inaccurately reported their caffeine intake, and the placebo effect could have influenced perceptions of how participants felt.

Atrial Fibrillation Explained

What is Atrial Fibrillation?

Atrial fibrillation (AFib) is a type of arrhythmia characterized by an irregular heart rhythm. The heart comprises four chambers that function to circulate blood effectively. The atria, the upper two chambers, are responsible for drawing blood into the heart. In patients with AFib, the rhythm of the atria becomes chaotic, leading to a heartbeat that may exceed 170 beats per minute at rest.

AFib can be a chronic condition, with episodes that may come and go. Atrial flutter, a related condition, causes the atria to beat rapidly, between 250 and 350 beats per minute, which can last from a few minutes to several months.

Common Treatments for Atrial Fibrillation

Doctors generally treat AFib with medications such as beta blockers and calcium channel blockers, or procedures like cardioversion. This outpatient procedure uses targeted electrical impulses to restore normal heart rhythm, with a success rate of about 92%. However, 42% of patients may experience another episode within a few years, prompting researchers to explore whether lifestyle modifications, such as coffee consumption, could help prevent recurrences.

Examining the DECAF Clinical Trial

Study Design and Participant Selection

The DECAF trial followed 200 patients who had undergone cardioversion for atrial fibrillation over six months. Participants were recruited from hospitals in San Francisco, Adelaide, and Toronto. Inclusion criteria focused on individuals over 21 who were regular coffee drinkers scheduled for cardioversion. Those with a life expectancy of less than six months, a history of substance abuse, prior heart surgery, or who did not drink coffee were excluded from the study.

The participants were randomly divided into two groups: one group abstained from coffee and caffeine for six months, while the other group consumed at least one cup of coffee daily during the same period.

Recurrence of Atrial Fibrillation

Cardiologists monitored the recurrence of atrial fibrillation in both groups over six months, defining recurrence as a clinical diagnosis or device-detected episode lasting over 30 seconds. They also tracked any adverse effects to ensure coffee consumption did not pose additional risks. Both groups were well-matched in terms of demographics and medical history to isolate the effects of coffee.

Conclusions from the Study

Coffee Consumption and Atrial Fibrillation Recurrence

The findings revealed that coffee consumption did not increase the likelihood of a recurrent atrial fibrillation episode within six months post-cardioversion. Notably, coffee drinkers experienced longer intervals before any recurrence compared to those who abstained. By the end of the trial, only 47% of coffee drinkers had another episode, compared to 64% of abstainers.

Consulting Your Doctor About Coffee Consumption

While the study suggests that coffee might not exacerbate heart arrhythmias, it is important to emphasize that further research is needed. The sample size was relatively small, and results may not apply universally to all patients with atrial fibrillation. For individuals diagnosed with AFib or atrial flutter considering changes to their coffee consumption, it is advisable to consult with a healthcare provider.

References

Wong CX, Cheung CC, Montenegro G, et al. Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation: The DECAF Randomized Clinical Trial. JAMA. Published online November 9, 2025. doi:10.1001/jama.2025.21056
Brandes A, Crijns HJGM, Rienstra M, et al. Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure. Europace. 2020;22(8):1149–1161. doi:10.1093/europace/euaa057